Results 51 to 60 of about 1,212 (129)
Raynaud´s phenomenon is a disorder with vasospasm of the peripherical arteries or arterioles, causing pallor, cianosis and rubor. It may be primary, where it is not associated with other diseases, or secondary to several diseases, including  ...
García, Lucy, Zapata, Karen
core
Following the COVID-19 pandemic, a new entity has emerged, the "post-COVID" syndrome, with multiple manifestations among which cardiovascular symptoms are mentioned.
Rodríguez, María +9 more
core
1. The novel tri-aryl ethane CDP840, is a potent and selective inhibitor of cyclic AMP phosphodiesterase type 4 (PDE 4) extracted from tissues or recombinant PDE 4 isoforms expressed in yeast (IC50S: 4-45 nM).
E. Boyd +49 more
core +1 more source
Introduction: Pancreatitis is one of the main consequences of scorpionic poisoning produced by the genus Tityus. The pharmacological management through the use of agonists and α adrenergic antagonists in experimental models in vivo and in ...
Domínguez, Zury +4 more
core +1 more source
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE. [PDF]
Mahfoud F +14 more
europepmc +1 more source
[Experience with topical brimonidine (Alphagan (R) 0,2%) in the treatment of glaucomas]
Purpose: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2 %, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core
Traitement des glaucomes par la brimonidine (Alphagan 0.2%).
PURPOSE: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2%, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core
Application of thermography in the diagnosis of the algodystrophic syndrome type I in 42-year-old patient [PDF]
Algodystrophic syndrome entity (type I) has not fully known pathogenesis and course. It is characterized by severe pain of the distal part of limb, oedema, vasomotor dysfunction and impaired efficiency.
Mróz, Józef +7 more
core
Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders. [PDF]
DePace NL +3 more
europepmc +1 more source
Papel do sistema simpático na disfunção cardiovascular do choque séptico [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas, Programa de Pós-Graduação em Farmacologia, Florianópolis, 2014.O choque séptico é um potente estímulo para a ativação de vários sistemas orgânicos e dentre ...
Favero, Ana Maria
core

